How severe is CVE-2019-10968?

CVE-2019-10968 has a CVSS 3.x base score of 4.4, rated medium severity. It is exploitable over local access with low attack complexity, requires high privileges and no user interaction. Impact on confidentiality is none, integrity high, and availability none.

Is CVE-2019-10968 being actively exploited?

It is not currently listed in CISA's KEV catalog. Its EPSS exploit-prediction score is 0% (25th percentile), an estimate of the probability of exploitation in the next 30 days.

What products are affected by CVE-2019-10968?

CVE-2019-10968 affects Philips Zymed Holter 2010. See the affected-products list for the exact vulnerable versions.

How do I fix CVE-2019-10968?

Review the linked vendor and NVD advisories for patched versions and mitigations, then upgrade or apply the recommended workaround.

When was CVE-2019-10968 published?

CVE-2019-10968 was published on 2019-07-24 and last updated on 2026-06-17.

CVE-2019-10968

CVE-2019-10968 is a medium-severity vulnerability in Philips Zymed Holter 2010 with a CVSS 3.x base score of 4.4. It is not currently listed as actively exploited by CISA, and its EPSS exploit-prediction score is low. The underlying weakness is classified as CWE-477.

Key facts

Severity: Medium (CVSS 3.x base score 4.4)
CVSS v2: 2.1
EPSS exploit prediction: 0% (25th percentile)
Actively exploited: Not listed in CISA KEV
Weakness: CWE-477
Affected product: Philips Zymed Holter 2010
Published: 2019-07-24
Last modified: 2026-06-17

Description

Philips Holter 2010 Plus, all versions. A vulnerability has been identified that may allow system options that were not purchased to be enabled.

Frequently asked questions

What is CVE-2019-10968?: Philips Holter 2010 Plus, all versions. A vulnerability has been identified that may allow system options that were not purchased to be enabled.
How severe is CVE-2019-10968?: CVE-2019-10968 has a CVSS 3.x base score of 4.4, rated medium severity. It is exploitable over local access with low attack complexity, requires high privileges and no user interaction. Impact on confidentiality is none, integrity high, and availability none.
Is CVE-2019-10968 being actively exploited?: It is not currently listed in CISA's KEV catalog. Its EPSS exploit-prediction score is 0% (25th percentile), an estimate of the probability of exploitation in the next 30 days.
What products are affected by CVE-2019-10968?: CVE-2019-10968 affects Philips Zymed Holter 2010. See the affected-products list for the exact vulnerable versions.
How do I fix CVE-2019-10968?: Review the linked vendor and NVD advisories for patched versions and mitigations, then upgrade or apply the recommended workaround.
When was CVE-2019-10968 published?: CVE-2019-10968 was published on 2019-07-24 and last updated on 2026-06-17.

References

https://www.us-cert.gov/ics/advisories/icsma-19-192-01

Affected products (1)

cpe:2.3:a:philips:zymed_holter_2010:*:*:*:*:plus:*:*:*

Other CWE-477 vulnerabilities

CVE-2025-49216 — Critical (CVSS 9.8): An authentication bypass vulnerability in the Trend Micro Endpoint Encryption PolicyServer could allow an attacker to…
CVE-2018-17890 — Critical (CVSS 9.8): NUUO CMS all versions 3.1 and prior, The application uses insecure and outdated software components for functionality,…
CVE-2019-18251 — High (CVSS 8.8): In Omron CX-Supervisor, Versions 3.5 (12) and prior, Omron CX-Supervisor ships with Teamviewer Version 5.0.8703 QS.…
CVE-2026-1693 — High (CVSS 7.5): The OAuth grant type Resource Owner Password Credentials (ROPC) flow is still used by the werbservices used by the…
CVE-2020-6978 — High (CVSS 7.2): In Honeywell WIN-PAK 4.7.2, Web and prior versions, the affected product is vulnerable due to the usage of old jQuery…
CVE-2023-28829 — Low (CVSS 3.9): A vulnerability has been identified in SIMATIC NET PC Software V14 (All versions), SIMATIC NET PC Software V15 (All…

Browse all CWE-477 vulnerabilities →